Journal Club: Bioengineering Birth... Again!

Daisy Wolf speaks with Dr. Andrew Huberman, professor of neurobiology and ophthalmology at Stanford University and host of the Huberman Lab podcast. They discuss how the pandemic sparked a consumer health revolution, the emerging peptide and GLP landscape, what the science actual ...  Show more

a16z Partners Daisy Wolf and Eva Steinman talk with Zach Cohen and Raymond Wang, cofounders of Ease Health, a company building an AI operating system for behavioral health that combines CRM, EHR, and revenue cycle management into a single platform. They discuss why behavioral hea ...  Show more

One of the most fundamental developmental stages we humans go through is extremely poorly understood. The first few days of the embryo, once it's been implanted in the womb is incredibly hard to study. Yet it's the time when the majority of pregnancies fail. Professor Magdalena Z ...  Show more

In the decade since the genome editing capabilities of CRISPR-Cas9 emerged, research into novel medicines has boomed – but alongside progress comes new ethical considerations. Controversy erupted in 2018, when Chinese scientist He Jiankui created the first babies with edited geno ...  Show more

In which we meet the pioneers of one of the most exciting — and controversial — fields of biomedical research: in vitro gametogenesis, or IVG. The goal of IVG is to make unlimited supplies of what Hayashi calls "artificial" eggs and sperm from any cell in the human body. That cou ...  Show more

In the decade since the genome editing capabilities of CRISPR-Cas9 emerged, research into novel medicines has boomed – but alongside progress comes new ethical considerations. Controversy erupted in 2018, when Chinese scientist He Jiankui created the first babies with edited geno ...  Show more